Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 16/1/2019
SIETES contiene 92637 citas

 1 a 20 de 150 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Young K. Diabetes guidelines updated. Journal Watch 2018:1. [Ref.ID 102893]
2. Cita con resumen
Schuster RM , Gilman J , Schoenfeld D , Evenden J , Hareli M , Ulysse C , Nip E , Hanly A , Zhang H , Evins E. One month of cannabis abstinence in adolescents and young adults is associated with improved memory. J Clin Psychiatry 2018;79:17m11977. [Ref.ID 102839]
3.Enlace a cita original Cita con resumen
Ramaekers JG. Driving under the influence of cannabis. An increasing public health concern. JAMA 2018;319:10 de abril. [Ref.ID 102668]
4. Cita con resumen
Vliegenthart ADB, Berends C, Potter CMJ, Kersaudy-Kerhoas M, Dear JW. MicroRNA-122 can be measured in capillary blood which facilitates point-of-care testing for drug-induced liver injury. Br J Clin Pharmacol 2017;83:2027-33. [Ref.ID 102028]
5. Cita con resumen
Schroeder LF, Guarner J, Eibireer A, Castle PE, Amukele TK. Time for a model list of essential diagnostics. N Engl J Med 2016;374:2511-4. [Ref.ID 100451]
7. Cita con resumen
Kaplan J, Shah P, Faley B, Siegel ME. Case reports of aripiprazole causing false-positive urine amphetamine drug screens in children. Pediatrics 2015;136:e1625-1628. [Ref.ID 99579]
8.Tiene citas relacionadas Cita con resumen
Grey A, Bolland M. Web of industry, advocacy, and academia in the management of osteoporosis. BMJ 2015;351:h3170. [Ref.ID 99391]
9.Tiene citas relacionadas Cita con resumen
Shine B, McKnight RF, Leaver L, Geddes JR. Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. Lancet 2015;386:461-8. [Ref.ID 99217]
10. Cita con resumen
Anónimo. FDA approves Lynparza to treat advanced ovarian cancer. FDA U.S. Food and Drug Administration 2014:19 de diciembre. [Ref.ID 98391]
11.Tiene citas relacionadas
Shlipak MG, Coresh J, Gansevoort RT. Cystatin C versus creatinine for kidney function-based risk. The authors reply. N Engl J Med 2013;369:2459. [Ref.ID 96682]
12.Tiene citas relacionadas
Vandecasteele SJ, De Vriese AS. Cystatin C versus creatinine for kidney function-based risk. N Engl J Med 2013;369:2458-9. [Ref.ID 96681]
13.Tiene citas relacionadas Cita con resumen
Cherney D, Maahs DM. Cystatin C versus creatinine for kidney function-based risk. N Engl J Med 2013;369:2458. [Ref.ID 96680]
14.Tiene citas relacionadas Cita con resumen
Tavares Jr AR. Cystatin C versus creatinine for kidney function-based risk. N Engl J Med 2013;369:2457-8. [Ref.ID 96679]
15.Tiene citas relacionadas Cita con resumen
Martin SS, Blaha MJ, Elshazly MB, Toth PP, Kwiterovich PO, Blumenthal RS, Jones SR. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA 2013;310:2061-8. [Ref.ID 96573]
16.Tiene citas relacionadas Cita con resumen
Gaziano JM, Gaziano TA. What's new with measuring cholesterol?. JAMA 2013;310:2043-944. [Ref.ID 96571]
17. Cita con resumen
Gigerenzer G, Wegwarth O. Five year survival rates can mislead. BMJ 2013;346:548. [Ref.ID 96564]
18. Cita con resumen
McCombs J, Matsuda T, Tonnu-Mihara I, Saab S, Hines P, L'Italien G, Juday T, Yuan Y. The risk of long-term morbidity and mortality in patients with chronic hepatitis C. Results from an analysis of data from a Department of Veterans Affairs clinical registry . JAMA Intern Med 2014;174:204-2012. [Ref.ID 96282]
19.Tiene citas relacionadas
Ingelfinger JR, Marsden PA. Estimated GFR and risk of death - Is cystatin C useful?. N Engl J Med 2013;369:974-5. [Ref.ID 96071]
20.Tiene citas relacionadas Cita con resumen
Shlipak MG, Mathushita K, Arnlov J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT, for the CKD Prognosis Consortium. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 2013;369:932-43. [Ref.ID 96070]
Seleccionar todas
 1 a 20 de 150 siguiente >>